Monensin-induced oxidative stress reduces prostate cancer cell motility and cancer stem cell markers

Kirsi Ketola, Mika Hilvo, Tuulia Hyötyläinen, Anu Vuoristo, Matej Oresic, Olli Kallioniemi, Kristiina Iljin

Research output: Contribution to journal › Other journal contribution › Scientific › peer-review

Original language	English
Journal	Molecular Cancer Therapeutics
Volume	10
Issue number	Supplement 11
DOIs	https://doi.org/10.1158/1535-7163.TARG-11-A62
Publication status	Published - 2011
MoE publication type	A1 Journal article-refereed
Event	AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics - San Francisco, United States Duration: 12 Nov 2011 → 16 Nov 2011 https://www.aacr.org/Documents/MolTar11_schedule.pdf (Conference Program)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8a7df34e40ae4c1195a95b921e4feaa1,

title = "Monensin-induced oxidative stress reduces prostate cancer cell motility and cancer stem cell markers",

author = "Kirsi Ketola and Mika Hilvo and Tuulia Hy{\"o}tyl{\"a}inen and Anu Vuoristo and Matej Oresic and Olli Kallioniemi and Kristiina Iljin",

year = "2011",

doi = "10.1158/1535-7163.TARG-11-A62",

language = "English",

volume = "10",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "Supplement 11",

note = "AACR-NCI-EORTC International Conference : Molecular Targets and Cancer Therapeutics ; Conference date: 12-11-2011 Through 16-11-2011",

url = "https://www.aacr.org/Documents/MolTar11_schedule.pdf",

}

TY - JOUR

T1 - Monensin-induced oxidative stress reduces prostate cancer cell motility and cancer stem cell markers

AU - Ketola, Kirsi

AU - Hilvo, Mika

AU - Hyötyläinen, Tuulia

AU - Vuoristo, Anu

AU - Oresic, Matej

AU - Kallioniemi, Olli

AU - Iljin, Kristiina

PY - 2011

Y1 - 2011

U2 - 10.1158/1535-7163.TARG-11-A62

DO - 10.1158/1535-7163.TARG-11-A62

M3 - Other journal contribution

SN - 1535-7163

VL - 10

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - Supplement 11

T2 - AACR-NCI-EORTC International Conference

Y2 - 12 November 2011 through 16 November 2011

ER -